Cardiovascular effects of ketanserin on normotensive rats in vivo and in vitro

Author： Orallo F.   Rosa E.   Garca-Ferreiro T.   Campos-Toimil M.   Cadavid M.I.   Loza M.I.  

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.35, Iss.2, 2000-08, pp. : 95-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ketanserin versus urapidil: age-related cardiovascular effects in conscious rats

By Bunag R.D.   Thomas C.V.   Mellick J.R.  

European Journal of Pharmacology, Vol. 435, Iss. 1, 2002-01 ,pp. : 85-92

Elsevier

Access to resources Recommend Favorite

Cardiovascular effects of centrally injected tetrahydroaminoacridine in conscious normotensive rats

By Savci V.   Gurun M.S.   Cavun S.   Ulus I.H.  

European Journal of Pharmacology, Vol. 346, Iss. 1, 1998-04 ,pp. : 35-41

Elsevier

Access to resources Recommend Favorite

Effects of low-dose ketanserin on atherosclerosis in rats and rabbits

By Yu Yong-Sheng   Xie He-Hui   Li Ling   Song Shu-Wei   Han Ping   Cai Guo-Jun   Su Ding-Feng  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 11, 2010-11 ,pp. : 1054-1060

NRC Research Press

Access to resources Recommend Favorite

In vivo and in vitro acute cardiovascular effects of bimoclomol

By Jednakovits A.   Ferdinandy P.   Jaszlits L.   Banyasz T.   Magyar J.   Szigligeti P.   Kortvely A.   Szentmiklosi J.A.   Nanasi P.P.  

General Pharmacology, Vol. 34, Iss. 5, 2000-05 ,pp. : 363-369

Elsevier

Access to resources Recommend Favorite

Study of in vivo and in vitro resting vasodilator nitric oxide tone in normotensive and genetically hypertensive rats

By Gil-Longo J.   Fdez-Grandal D.   Alvarez M.   Sieira M.   Orallo F.  

European Journal of Pharmacology, Vol. 310, Iss. 2, 1996-08 ,pp. : 175-183

Elsevier

Access to resources Recommend Favorite